US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Progress

43.54

+0.21000.48%

Post-market: 43.540.00000.00%17:01 EST

Volume:389.79K

Turnover:16.97M

Market Cap:1.87B

PE:39.83

High:43.95

Open:43.30

Low:43.26

Close:43.33

52wk High:69.88

52wk Low:39.00

Shares:42.91M

Float Shares:42.59M

Volume Ratio:0.90

T/O Rate:0.92%

Dividend:- -

Dividend Rate:- -

EPS(TTM):1.09

EPS(LYR):1.58

ROE:10.75%

ROA:5.39%

PB:3.91

PE(LYR):27.53

Loading ...

Overview Company News Filings

United Natural Foods (UNFI): Reassessing Valuation After a Strong Q1 Earnings Beat and Turnaround Progress

Simply Wall St.

Bicara Therapeutics (BCAX): Assessing Valuation After Breakthrough Therapy Designation and Early Trial Data Progress

Simply Wall St.

Assessing Agnico Eagle Mines (NYSE:AEM) Valuation After Record Profits, Strong Cash Flows and Growth Project Progress

Simply Wall St.

QuantumScape (QS) Valuation Check After Cobra Separator Breakthrough and New OEM Partnership Progress

Simply Wall St.

Beam Therapeutics (BEAM) Is Up 6.8% After Analyst Optimism Around Sickle Cell Base-Editing Progress - What's Changed

Simply Wall St.

Press Release: MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress

Xtep (SEHK:1368): Reassessing Valuation After Updated Guidance, Saucony Growth Plans, and Inventory Progress

Simply Wall St.

Oil Gains on Market Concerns Over Russia-Ukraine Progress -- Market Talk

Today's Top 3 News: PT GoTo Gojek Tokopedia Responds to Grab Merger Progress: "Open to Discussions"

Royal Group Celebrates the Success of "Rise for Khmer" Concert, Reaffirming Its Commitment to Culture, Unity, and National Progress

Did FDA Green Light for ELEVIDYS and Pipeline Progress Just Shift Sarepta Therapeutics' (SRPT) Narrative?

Simply Wall St.

A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Q3 2025 Results and Pipeline Progress

Simply Wall St.

Assessing SSY Group (SEHK:2005) Valuation Following New Drug Approvals and Pipeline Progress

Simply Wall St.

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

Press Release: Pulse Oil Corp. Announces Amendments to Facility Agreements and Updates EOR Progress

Sean Duffy Says Airbus A320 Software Recall Won't Cause 'Major' Disruptions For Travelers: 'Great Progress...'

Benzinga_recent_news

Avis Budget Group (CAR): Valuation in Focus After Strong Q3 Results and International Expansion Progress

Simply Wall St.

Is Arrowhead a Bargain After Clinical Trial Progress Fuels 168% Jump in 2025?

Simply Wall St.

Ultragenyx Pharmaceutical (RARE): Evaluating Valuation After Analyst Commentary on Setrusumab Progress and Growth Outlook

Simply Wall St.

Prabowo Claims His First Year in Office Has Shown Tangible Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PRGS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRGS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRGS\",,,,,undefined,":{"symbol":"PRGS","market":"US","secType":"STK","nameCN":"Progress","latestPrice":43.54,"timestamp":1764968400000,"preClose":43.33,"halted":0,"volume":389792,"hourTrading":{"tag":"盘后","latestPrice":43.54,"preClose":43.54,"latestTime":"17:01 EST","volume":16636,"amount":724330.8,"timestamp":1764972074055},"delay":0,"floatShares":42593818,"shares":42907573,"eps":1.093117,"marketStatus":"Market Closed","change":0.21,"latestTime":"12-05 16:00:00 EST","open":43.3,"high":43.95,"low":43.26,"amount":16972552.071904,"amplitude":0.015924,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.093117,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":680760000000,"exchange":"NASDAQ","adjPreClose":43.33,"postHourTrading":{"tag":"盘后","latestPrice":43.54,"preClose":43.54,"latestTime":"17:01 EST","volume":16636,"amount":724330.8,"timestamp":1764972074055},"volumeRatio":0.9007570860905291,"impliedVol":0.5476,"impliedVolPercentile":0.868},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRGS\",,,,,undefined,":{"symbol":"PRGS","floatShares":42593818,"roa":"5.39%","roe":"10.75%","lyrEps":1.581723,"volumeRatio":0.9007570860905291,"shares":42907573,"dividePrice":0,"high":43.95,"amplitude":0.015924,"preClose":43.33,"low":43.26,"week52Low":39,"pbRate":"3.91","psRate":"1.99","week52High":69.88,"institutionHeld":0.9482,"latestPrice":43.54,"eps":1.093117,"divideRate":0,"volume":389792,"delay":0,"ttmEps":1.093117,"open":43.3,"prevYearClose":65.15,"prevWeekClose":41.41,"prevMonthClose":41.41,"prevQuarterClose":43.93,"fiveDayClose":41.41,"twentyDayClose":41.96,"sixtyDayClose":43.01,"dividendPayoutRate":0.3319165239425613,"dividendFrequency":"Q","dividendGrowthYears":0,"dividendGrowthRate":-0.24999999999999992,"fiveYearAvgDividendRate":0.012866073843011212},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRGS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-09-29","symbol":"PRGS","fiscalQuarterEnding":"2025/08","expectedEps":1.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"post","actualEps":1.19},{"date":"2025-06-30","symbol":"PRGS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/05","expectedEps":1.01,"defaultRemindTime":1751313600000,"name":null,"time":"Post Market","dateTimestamp":1751256000000,"actualEps":null},{"market":"US","date":"2025-03-31","symbol":"PRGS","fiscalQuarterEnding":"2025/02","expectedEps":0.79,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":1.07},{"market":"US","date":"2025-01-21","symbol":"PRGS","fiscalQuarterEnding":"2024/11","expectedEps":1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1737435600000,"reportTimeType":"post","actualEps":1.07},{"market":"US","date":"2024-09-24","symbol":"PRGS","fiscalQuarterEnding":"2024/08","expectedEps":0.93,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1727150400000,"reportTimeType":"post","actualEps":1.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRGS\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-29","recordDate":"2016-12-01","paymentDate":"2016-12-15","value":0.125,"currency":"USD"},{"executeDate":"2017-02-27","recordDate":"2017-03-01","paymentDate":"2017-03-15","value":0.125,"currency":"USD"},{"executeDate":"2017-05-30","recordDate":"2017-06-01","paymentDate":"2017-06-15","value":0.125,"currency":"USD"},{"executeDate":"2017-08-30","recordDate":"2017-09-01","paymentDate":"2017-09-15","value":0.125,"currency":"USD"},{"executeDate":"2017-11-30","recordDate":"2017-12-01","paymentDate":"2017-12-15","value":0.14,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRGS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.1667,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1760245200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRGS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRGS","date":"2025-12-05","current":39.831052,"percent":0.92403,"low":18.81145,"twenty":25.116647,"median":28.447032,"eighty":34.591182,"high":49.027418,"avg":30.041284,"sd":6.007204,"marketCap":1859185138},"quantilePoints":[{"date":"2020-12-11","current":32.975891,"twenty":26.45311,"median":36.306384,"eighty":65.738594,"marketCap":1890211073},{"date":"2020-12-18","current":34.628227,"twenty":26.617231,"median":36.306384,"eighty":65.738594,"marketCap":1984924584},{"date":"2020-12-24","current":34.777724,"twenty":26.918654,"median":36.306384,"eighty":65.738594,"marketCap":1993493902},{"date":"2020-12-31","current":35.556682,"twenty":27.002186,"median":36.306384,"eighty":65.738594,"marketCap":2038144557},{"date":"2021-01-08","current":37.224754,"twenty":27.421184,"median":36.445418,"eighty":65.738594,"marketCap":2133760102},{"date":"2021-01-15","current":24.971624,"twenty":27.501919,"median":36.651258,"eighty":65.738594,"marketCap":1990787802},{"date":"2021-01-22","current":23.743975,"twenty":27.501919,"median":36.651258,"eighty":65.738594,"marketCap":1892917173},{"date":"2021-01-29","current":22.285053,"twenty":27.501919,"median":36.651258,"eighty":65.738594,"marketCap":1776608965},{"date":"2021-02-05","current":23.494147,"twenty":27.501919,"median":36.651258,"eighty":65.738594,"marketCap":1873000392},{"date":"2021-02-12","current":24.070963,"twenty":27.501919,"median":36.651258,"eighty":65.738594,"marketCap":1918985293},{"date":"2021-02-19","current":24.947279,"twenty":27.501919,"median":36.651258,"eighty":65.738594,"marketCap":1988846969},{"date":"2021-02-26","current":23.593981,"twenty":27.501919,"median":36.651258,"eighty":65.738594,"marketCap":1880959317},{"date":"2021-03-05","current":24.192981,"twenty":27.551936,"median":36.651663,"eighty":65.760971,"marketCap":1928712868},{"date":"2021-03-12","current":25.207955,"twenty":27.551936,"median":36.651663,"eighty":65.760971,"marketCap":2009628607},{"date":"2021-03-19","current":24.326093,"twenty":27.551936,"median":36.651663,"eighty":65.760971,"marketCap":1939324768},{"date":"2021-03-26","current":25.235647,"twenty":27.501919,"median":36.651258,"eighty":65.738594,"marketCap":1957453431},{"date":"2021-04-01","current":25.550783,"twenty":27.501919,"median":36.651258,"eighty":65.738594,"marketCap":1981897597},{"date":"2021-04-09","current":25.40896,"twenty":27.494103,"median":36.651663,"eighty":65.760971,"marketCap":1970896833},{"date":"2021-04-16","current":25.800391,"twenty":27.347177,"median":36.651663,"eighty":65.760971,"marketCap":2001258941},{"date":"2021-04-23","current":26.44143,"twenty":26.983429,"median":36.651663,"eighty":65.760971,"marketCap":2050982393},{"date":"2021-04-30","current":24.767922,"twenty":26.632861,"median":36.651663,"eighty":65.760971,"marketCap":1921173381},{"date":"2021-05-07","current":25.05724,"twenty":26.534693,"median":36.651663,"eighty":65.760971,"marketCap":1943614939},{"date":"2021-05-14","current":25.113969,"twenty":26.409593,"median":36.651663,"eighty":65.760971,"marketCap":1948015244},{"date":"2021-05-21","current":24.807632,"twenty":26.251476,"median":36.651663,"eighty":65.760971,"marketCap":1924253595},{"date":"2021-05-28","current":25.284156,"twenty":25.954496,"median":36.651663,"eighty":65.760971,"marketCap":1961216161},{"date":"2021-06-04","current":26.157784,"twenty":25.863839,"median":36.651663,"eighty":65.760971,"marketCap":2028980866},{"date":"2021-06-11","current":27.315058,"twenty":25.863839,"median":36.651663,"eighty":65.760971,"marketCap":2118747098},{"date":"2021-06-18","current":25.675587,"twenty":25.824763,"median":36.651663,"eighty":65.760971,"marketCap":1991578269},{"date":"2021-06-25","current":27.598334,"twenty":25.819101,"median":36.651663,"eighty":65.760971,"marketCap":2046582088},{"date":"2021-07-02","current":28.073042,"twenty":25.819101,"median":36.618187,"eighty":65.760971,"marketCap":2081784532},{"date":"2021-07-09","current":27.059074,"twenty":25.819101,"median":36.291981,"eighty":65.760971,"marketCap":2006592697},{"date":"2021-07-16","current":26.233023,"twenty":25.819101,"median":35.821466,"eighty":65.760971,"marketCap":1945336051},{"date":"2021-07-23","current":27.300989,"twenty":25.819101,"median":35.518994,"eighty":65.760971,"marketCap":2024532143},{"date":"2021-07-30","current":26.899764,"twenty":25.819101,"median":35.425942,"eighty":65.760971,"marketCap":1994778915},{"date":"2021-08-06","current":27.295089,"twenty":25.819101,"median":35.296819,"eighty":65.760971,"marketCap":2024094596},{"date":"2021-08-13","current":26.811259,"twenty":25.819101,"median":35.22023,"eighty":65.760971,"marketCap":1988215703},{"date":"2021-08-20","current":26.162219,"twenty":25.810602,"median":35.044648,"eighty":65.760971,"marketCap":1940085481},{"date":"2021-08-27","current":27.879225,"twenty":25.810602,"median":34.900097,"eighty":65.760971,"marketCap":2067411795},{"date":"2021-09-03","current":27.584207,"twenty":25.810602,"median":34.802675,"eighty":65.760971,"marketCap":2045534422},{"date":"2021-09-10","current":26.764056,"twenty":25.810602,"median":34.696848,"eighty":65.760971,"marketCap":1984715323},{"date":"2021-09-17","current":27.194782,"twenty":25.810602,"median":34.619571,"eighty":65.760971,"marketCap":2016656289},{"date":"2021-09-24","current":28.628884,"twenty":25.806064,"median":34.555296,"eighty":65.760971,"marketCap":2323377065},{"date":"2021-10-01","current":26.860471,"twenty":25.806064,"median":34.507658,"eighty":65.760971,"marketCap":2179861495},{"date":"2021-10-08","current":26.514593,"twenty":25.806064,"median":34.438441,"eighty":65.661871,"marketCap":2151791814},{"date":"2021-10-15","current":27.108849,"twenty":25.806064,"median":34.354044,"eighty":64.275527,"marketCap":2200018607},{"date":"2021-10-22","current":27.632874,"twenty":25.806064,"median":34.300826,"eighty":62.694875,"marketCap":2242545869},{"date":"2021-10-29","current":27.773334,"twenty":25.806064,"median":34.167974,"eighty":59.444271,"marketCap":2253944929},{"date":"2021-11-05","current":28.221727,"twenty":25.806064,"median":34.108443,"eighty":55.556032,"marketCap":2290334237},{"date":"2021-11-12","current":28.210922,"twenty":25.806064,"median":34.029261,"eighty":52.35114,"marketCap":2289457386},{"date":"2021-11-19","current":28.351382,"twenty":25.806064,"median":33.965855,"eighty":50.642427,"marketCap":2300856446},{"date":"2021-11-26","current":26.357926,"twenty":25.806064,"median":33.911696,"eighty":49.251547,"marketCap":2139077477},{"date":"2021-12-03","current":26.411949,"twenty":25.806064,"median":33.849872,"eighty":48.780144,"marketCap":2143461731},{"date":"2021-12-10","current":26.179649,"twenty":25.806064,"median":33.813941,"eighty":48.070929,"marketCap":2124609439},{"date":"2021-12-17","current":25.277462,"twenty":25.752738,"median":33.769227,"eighty":47.820523,"marketCap":2051392399},{"date":"2021-12-23","current":26.104017,"twenty":25.69374,"median":33.736473,"eighty":47.644524,"marketCap":2118471484},{"date":"2021-12-31","current":26.077005,"twenty":25.69374,"median":33.657495,"eighty":47.479592,"marketCap":2116279357},{"date":"2022-01-07","current":24.650792,"twenty":25.656299,"median":33.617593,"eighty":47.158987,"marketCap":2000535054},{"date":"2022-01-14","current":24.80746,"twenty":25.582638,"median":33.544867,"eighty":47.084303,"marketCap":2013249390},{"date":"2022-01-21","current":24.878768,"twenty":25.526483,"median":33.473699,"eighty":46.995008,"marketCap":1950992985},{"date":"2022-01-28","current":25.735827,"twenty":25.462515,"median":33.407153,"eighty":46.923028,"marketCap":2018203519},{"date":"2022-02-04","current":25.273844,"twenty":25.430444,"median":33.338006,"eighty":46.773605,"marketCap":1981974822},{"date":"2022-02-11","current":25.352719,"twenty":25.421495,"median":33.298868,"eighty":46.720696,"marketCap":1988160210},{"date":"2022-02-18","current":24.778057,"twenty":25.381666,"median":33.216837,"eighty":46.59349,"marketCap":1943095245},{"date":"2022-02-25","current":24.907638,"twenty":25.361663,"median":33.172459,"eighty":46.355101,"marketCap":1953256952},{"date":"2022-03-04","current":24.947075,"twenty":25.340579,"median":33.111518,"eighty":46.188231,"marketCap":1956349646},{"date":"2022-03-11","current":24.704816,"twenty":25.313281,"median":33.064287,"eighty":45.995999,"marketCap":1937351671},{"date":"2022-03-18","current":25.533005,"twenty":25.28899,"median":32.995762,"eighty":45.764886,"marketCap":2002298238},{"date":"2022-03-25","current":25.02595,"twenty":25.272503,"median":32.935787,"eighty":45.516351,"marketCap":1962535033},{"date":"2022-04-01","current":26.040081,"twenty":25.265285,"median":32.863231,"eighty":45.402658,"marketCap":2080941019},{"date":"2022-04-08","current":25.133378,"twenty":25.253427,"median":32.75558,"eighty":45.360936,"marketCap":2008483625},{"date":"2022-04-14","current":26.003554,"twenty":25.265285,"median":32.75558,"eighty":45.360936,"marketCap":2078022024},{"date":"2022-04-22","current":26.518368,"twenty":25.293008,"median":32.75558,"eighty":45.360936,"marketCap":2119162309},{"date":"2022-04-29","current":26.277391,"twenty":25.313571,"median":32.75558,"eighty":45.360936,"marketCap":2099905154},{"date":"2022-05-06","current":25.609229,"twenty":25.344214,"median":32.75558,"eighty":45.360936,"marketCap":2046510317},{"date":"2022-05-13","current":25.773531,"twenty":25.351444,"median":32.75558,"eighty":45.360936,"marketCap":2059640195},{"date":"2022-05-20","current":25.576369,"twenty":25.379417,"median":32.75558,"eighty":45.360936,"marketCap":2043884342},{"date":"2022-05-27","current":26.48003,"twenty":25.421495,"median":32.75558,"eighty":45.360936,"marketCap":2116098671},{"date":"2022-06-03","current":27.328925,"twenty":25.446428,"median":32.75558,"eighty":45.360936,"marketCap":2183936374},{"date":"2022-06-10","current":26.556705,"twenty":25.469327,"median":32.75558,"eighty":45.360936,"marketCap":2122225947},{"date":"2022-06-17","current":25.702334,"twenty":25.521737,"median":32.75558,"eighty":45.360936,"marketCap":2053950581},{"date":"2022-06-24","current":28.238063,"twenty":25.545817,"median":32.763448,"eighty":45.362316,"marketCap":2256588365},{"date":"2022-07-01","current":20.643943,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1970794687},{"date":"2022-07-08","current":20.67145,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1973420663},{"date":"2022-07-15","current":20.318369,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1939713433},{"date":"2022-07-22","current":20.919316,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1997083403},{"date":"2022-07-29","current":21.379131,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2040980122},{"date":"2022-08-05","current":21.552131,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2057495719},{"date":"2022-08-12","current":22.571919,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2154850818},{"date":"2022-08-19","current":23.054497,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2200920642},{"date":"2022-08-26","current":22.134867,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2113127204},{"date":"2022-09-02","current":21.074105,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2011860516},{"date":"2022-09-09","current":21.465631,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":2049237920},{"date":"2022-09-16","current":19.52166,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1863654762},{"date":"2022-09-23","current":19.15745,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1828885083},{"date":"2022-09-30","current":21.432108,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1849312269},{"date":"2022-10-07","current":22.610748,"twenty":25.548073,"median":32.763448,"eighty":45.362316,"marketCap":1951013579},{"date":"2022-10-14","current":22.847858,"twenty":25.528498,"median":32.739844,"eighty":45.260277,"marketCap":1971473109},{"date":"2022-10-21","current":23.929207,"twenty":25.484412,"median":32.683737,"eighty":45.157758,"marketCap":2064779470},{"date":"2022-10-28","current":25.269681,"twenty":25.455327,"median":32.587399,"eighty":44.991293,"marketCap":2180444959},{"date":"2022-11-04","current":24.706582,"twenty":25.426459,"median":32.517016,"eighty":44.88775,"marketCap":2131856854},{"date":"2022-11-11","current":25.847729,"twenty":25.399985,"median":32.471829,"eighty":44.796127,"marketCap":2230323014},{"date":"2022-11-18","current":25.713184,"twenty":25.399985,"median":32.351753,"eighty":44.671865,"marketCap":2218713466},{"date":"2022-11-25","current":26.485576,"twenty":25.399985,"median":32.195223,"eighty":44.624386,"marketCap":2285360867},{"date":"2022-12-02","current":26.86928,"twenty":25.399985,"median":32.135964,"eighty":44.585713,"marketCap":2318469576},{"date":"2022-12-09","current":25.763015,"twenty":25.399985,"median":32.055305,"eighty":44.481345,"marketCap":2223013299},{"date":"2022-12-16","current":25.399243,"twenty":25.394155,"median":31.936775,"eighty":44.370506,"marketCap":2191624523},{"date":"2022-12-23","current":25.145102,"twenty":25.36657,"median":31.878678,"eighty":44.308273,"marketCap":2169695378},{"date":"2022-12-30","current":25.140118,"twenty":25.343523,"median":31.795682,"eighty":44.250723,"marketCap":2169265395},{"date":"2023-01-06","current":25.94241,"twenty":25.36657,"median":31.795682,"eighty":44.250723,"marketCap":2238492695},{"date":"2023-01-13","current":26.789549,"twenty":25.378239,"median":31.704386,"eighty":44.185759,"marketCap":2311589844},{"date":"2023-01-20","current":23.496228,"twenty":25.35017,"median":31.62255,"eighty":44.110351,"marketCap":2233762879},{"date":"2023-01-27","current":23.894239,"twenty":25.313644,"median":31.417975,"eighty":43.987218,"marketCap":2271601404},{"date":"2023-02-03","current":25.837838,"twenty":25.313281,"median":31.306166,"eighty":43.820895,"marketCap":2456377414},{"date":"2023-02-10","current":26.052127,"twenty":25.313281,"median":31.197684,"eighty":43.702315,"marketCap":2476749699},{"date":"2023-02-17","current":26.357604,"twenty":25.313281,"median":30.990623,"eighty":43.430265,"marketCap":2505791041},{"date":"2023-02-24","current":26.020212,"twenty":25.313281,"median":30.741305,"eighty":43.286901,"marketCap":2473715529},{"date":"2023-03-03","current":26.836336,"twenty":25.313281,"median":30.476049,"eighty":43.140932,"marketCap":2551303592},{"date":"2023-03-10","current":25.623548,"twenty":25.313281,"median":30.418706,"eighty":42.95958,"marketCap":2436005129},{"date":"2023-03-17","current":26.248179,"twenty":25.313281,"median":29.502053,"eighty":42.746934,"marketCap":2495388172},{"date":"2023-03-24","current":26.325688,"twenty":25.313281,"median":28.729545,"eighty":42.638559,"marketCap":2502756871},{"date":"2023-03-31","current":25.335355,"twenty":25.305985,"median":28.529626,"eighty":42.617599,"marketCap":2490186738},{"date":"2023-04-06","current":24.00354,"twenty":25.293008,"median":28.43459,"eighty":42.617599,"marketCap":2359283971},{"date":"2023-04-14","current":25.031071,"twenty":25.268664,"median":28.314706,"eighty":42.619802,"marketCap":2460278907},{"date":"2023-04-21","current":24.846014,"twenty":25.235585,"median":28.238063,"eighty":42.619802,"marketCap":2442089906},{"date":"2023-04-28","current":24.211536,"twenty":25.180224,"median":28.073042,"eighty":42.619802,"marketCap":2379727617},{"date":"2023-05-05","current":23.572651,"twenty":25.160136,"median":27.854369,"eighty":42.619802,"marketCap":2316932257},{"date":"2023-05-10","current":23.850235,"twenty":25.151082,"median":27.800346,"eighty":42.619802,"marketCap":2344215758},{"date":"2023-05-18","current":24.964979,"twenty":25.140118,"median":27.716839,"eighty":42.626409,"marketCap":2453782835},{"date":"2023-05-24","current":25.832981,"twenty":25.137422,"median":27.642018,"eighty":42.626409,"marketCap":2539097911},{"date":"2023-06-02","current":26.238343,"twenty":25.133378,"median":27.603517,"eighty":42.626409,"marketCap":2578940484},{"date":"2023-06-06","current":26.357308,"twenty":25.132175,"median":27.596024,"eighty":42.632484,"marketCap":2590633413},{"date":"2023-06-15","current":26.982974,"twenty":25.127361,"median":27.542904,"eighty":42.656785,"marketCap":2652129559},{"date":"2023-06-23","current":25.097162,"twenty":25.118263,"median":27.478473,"eighty":42.660789,"marketCap":2466774979},{"date":"2023-06-30","current":29.244806,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2376696117},{"date":"2023-07-07","current":30.262619,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2459412764},{"date":"2023-07-14","current":31.050782,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2523465968},{"date":"2023-07-21","current":31.002757,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2519563031},{"date":"2023-07-28","current":31.008093,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2519996691},{"date":"2023-08-04","current":32.379471,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2631447241},{"date":"2023-08-11","current":32.005944,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2601091060},{"date":"2023-08-18","current":31.221537,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2537343080},{"date":"2023-08-25","current":32.336782,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2627977963},{"date":"2023-09-01","current":32.464849,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2638385797},{"date":"2023-09-08","current":31.130823,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2529970864},{"date":"2023-09-15","current":30.735952,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2497880044},{"date":"2023-09-22","current":30.042258,"twenty":25.113265,"median":27.441726,"eighty":42.669175,"marketCap":2441504279},{"date":"2023-09-29","current":29.446031,"twenty":25.112561,"median":27.439397,"eighty":42.674891,"marketCap":2313574659},{"date":"2023-10-06","current":28.513251,"twenty":25.112561,"median":27.514023,"eighty":42.674891,"marketCap":2240286165},{"date":"2023-10-13","current":29.293079,"twenty":25.112561,"median":27.556797,"eighty":42.674891,"marketCap":2301557229},{"date":"2023-10-20","current":28.472452,"twenty":25.111856,"median":27.600926,"eighty":42.680606,"marketCap":2237080517},{"date":"2023-10-27","current":28.051048,"twenty":25.125541,"median":27.632874,"eighty":42.697564,"marketCap":2203970854},{"date":"2023-11-03","current":27.540928,"twenty":25.141891,"median":27.736377,"eighty":42.697564,"marketCap":2163890735},{"date":"2023-11-10","current":28.716422,"twenty":25.141891,"median":27.838262,"eighty":42.697564,"marketCap":2256249269},{"date":"2023-11-17","current":29.675669,"twenty":25.141891,"median":28.023324,"eighty":42.697564,"marketCap":2331617317},{"date":"2023-11-24","current":29.659035,"twenty":25.141891,"median":28.13422,"eighty":42.697564,"marketCap":2330310357},{"date":"2023-12-01","current":29.864192,"twenty":25.141891,"median":28.238063,"eighty":42.697564,"marketCap":2346429535},{"date":"2023-12-08","current":29.437243,"twenty":25.141891,"median":28.27575,"eighty":42.697564,"marketCap":2312884219},{"date":"2023-12-15","current":30.795715,"twenty":25.141891,"median":28.351382,"eighty":42.697564,"marketCap":2419619316},{"date":"2023-12-22","current":30.485207,"twenty":25.141891,"median":28.421613,"eighty":42.697564,"marketCap":2395222723},{"date":"2023-12-29","current":30.180244,"twenty":25.141448,"median":28.480769,"eighty":42.70309,"marketCap":2371261782},{"date":"2024-01-05","current":29.049109,"twenty":25.141004,"median":28.513251,"eighty":42.708617,"marketCap":2282388476},{"date":"2024-01-12","current":29.570318,"twenty":25.141004,"median":28.628884,"eighty":42.708617,"marketCap":2323339902},{"date":"2024-01-19","current":35.890194,"twenty":25.140561,"median":28.764903,"eighty":42.714143,"marketCap":2519383959},{"date":"2024-01-26","current":36.579077,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2567741493},{"date":"2024-02-02","current":36.212094,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2541980333},{"date":"2024-02-09","current":35.868288,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2517846220},{"date":"2024-02-16","current":35.224434,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2472649608},{"date":"2024-02-23","current":34.255528,"twenty":25.141004,"median":28.800261,"eighty":42.708617,"marketCap":2404635288},{"date":"2024-03-01","current":33.355383,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2341447792},{"date":"2024-03-08","current":33.699188,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2365581905},{"date":"2024-03-15","current":33.09284,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2323018105},{"date":"2024-03-22","current":33.061585,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2320824095},{"date":"2024-03-28","current":33.391389,"twenty":25.141448,"median":28.809468,"eighty":42.70309,"marketCap":2309415241},{"date":"2024-04-05","current":32.395294,"twenty":25.141004,"median":28.800261,"eighty":42.622004,"marketCap":2240523318},{"date":"2024-04-12","current":32.287651,"twenty":25.141004,"median":28.800261,"eighty":42.404436,"marketCap":2233078503},{"date":"2024-04-19","current":31.362825,"twenty":25.141004,"median":28.800261,"eighty":42.07362,"marketCap":2169115736},{"date":"2024-04-26","current":31.681515,"twenty":25.141448,"median":28.809468,"eighty":41.925727,"marketCap":2191156960},{"date":"2024-05-03","current":31.519046,"twenty":25.141448,"median":28.809468,"eighty":41.692905,"marketCap":2179920257},{"date":"2024-05-10","current":31.756501,"twenty":25.141448,"median":28.809468,"eighty":41.605205,"marketCap":2196343130},{"date":"2024-05-17","current":32.306397,"twenty":25.141448,"median":28.809468,"eighty":41.374011,"marketCap":2234375046},{"date":"2024-05-24","current":31.606529,"twenty":25.141448,"median":28.809468,"eighty":41.232151,"marketCap":2185970789},{"date":"2024-05-31","current":30.931657,"twenty":25.141448,"median":28.809468,"eighty":40.957916,"marketCap":2139295257},{"date":"2024-06-07","current":31.281591,"twenty":25.141448,"median":28.809468,"eighty":40.957916,"marketCap":2163497385},{"date":"2024-06-14","current":31.256596,"twenty":25.141004,"median":28.800261,"eighty":40.758432,"marketCap":2161768661},{"date":"2024-06-21","current":30.11931,"twenty":25.140561,"median":28.764903,"eighty":39.595792,"marketCap":2083111745},{"date":"2024-06-28","current":31.997666,"twenty":25.140118,"median":28.716422,"eighty":37.803838,"marketCap":2344148984},{"date":"2024-07-05","current":32.109752,"twenty":25.140118,"median":28.716422,"eighty":37.303436,"marketCap":2352360420},{"date":"2024-07-12","current":32.079419,"twenty":25.140118,"median":28.716422,"eighty":37.176219,"marketCap":2350138272},{"date":"2024-07-15","current":32.19036,"twenty":25.140118,"median":28.716422,"eighty":37.131908,"marketCap":2358265798},{"date":"2024-08-02","current":33.469099,"twenty":25.127361,"median":28.480769,"eighty":36.603511,"marketCap":2451946228},{"date":"2024-08-09","current":32.774259,"twenty":25.127361,"median":28.480769,"eighty":36.277577,"marketCap":2401042250},{"date":"2024-08-16","current":33.101243,"twenty":25.127361,"median":28.480769,"eighty":35.980806,"marketCap":2424997063},{"date":"2024-08-23","current":33.107082,"twenty":25.127361,"median":28.480769,"eighty":35.868288,"marketCap":2425424828},{"date":"2024-08-30","current":34.017965,"twenty":25.127361,"median":28.480769,"eighty":35.718264,"marketCap":2492156093},{"date":"2024-09-06","current":33.679303,"twenty":25.127361,"median":28.480769,"eighty":35.538198,"marketCap":2467345751},{"date":"2024-09-13","current":33.439905,"twenty":25.127361,"median":28.480769,"eighty":35.480584,"marketCap":2449807406},{"date":"2024-09-20","current":33.673464,"twenty":25.127361,"median":28.480769,"eighty":35.352107,"marketCap":2466917986},{"date":"2024-09-27","current":34.086142,"twenty":25.127361,"median":28.480769,"eighty":35.269333,"marketCap":2816401599},{"date":"2024-10-04","current":33.552899,"twenty":25.127361,"median":28.480769,"eighty":35.095806,"marketCap":2772341854},{"date":"2024-10-11","current":33.866649,"twenty":25.127361,"median":28.480769,"eighty":35.005903,"marketCap":2798265730},{"date":"2024-10-18","current":34.443036,"twenty":25.127361,"median":28.480769,"eighty":34.866036,"marketCap":2845890308},{"date":"2024-10-25","current":33.814722,"twenty":25.127361,"median":28.480769,"eighty":34.668094,"marketCap":2793975228},{"date":"2024-10-31","current":33.586244,"twenty":25.127361,"median":28.480769,"eighty":34.593624,"marketCap":2775097017},{"date":"2024-11-08","current":35.003845,"twenty":25.124683,"median":28.472452,"eighty":34.474261,"marketCap":2892227735},{"date":"2024-11-15","current":34.920763,"twenty":25.124683,"median":28.472452,"eighty":34.474261,"marketCap":2885362931},{"date":"2024-11-22","current":35.689279,"twenty":25.124683,"median":28.472452,"eighty":34.42807,"marketCap":2948862368},{"date":"2024-11-29","current":35.523113,"twenty":25.124683,"median":28.472452,"eighty":34.42807,"marketCap":2935132760},{"date":"2024-12-06","current":35.647738,"twenty":25.124683,"median":28.472452,"eighty":34.42807,"marketCap":2945429966},{"date":"2024-12-13","current":36.15662,"twenty":25.124683,"median":28.472452,"eighty":34.42807,"marketCap":2987476890},{"date":"2024-12-20","current":34.230136,"twenty":25.124683,"median":28.472452,"eighty":34.396717,"marketCap":2828299248},{"date":"2024-12-27","current":34.476789,"twenty":25.124683,"median":28.472452,"eighty":34.396717,"marketCap":2848679134},{"date":"2025-01-03","current":33.601822,"twenty":25.124683,"median":28.472452,"eighty":34.355231,"marketCap":2776384167},{"date":"2025-01-10","current":32.885233,"twenty":25.122004,"median":28.462046,"eighty":34.30718,"marketCap":2717175233},{"date":"2025-01-17","current":33.087747,"twenty":25.122004,"median":28.462046,"eighty":34.198287,"marketCap":2733908193},{"date":"2025-01-24","current":34.296248,"twenty":25.122004,"median":28.462046,"eighty":34.179804,"marketCap":2347166594},{"date":"2025-01-31","current":36.121325,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2472071247},{"date":"2025-02-07","current":36.260741,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2481612574},{"date":"2025-02-14","current":36.697999,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2511537647},{"date":"2025-02-21","current":35.842494,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2452988591},{"date":"2025-02-28","current":34.416652,"twenty":25.122004,"median":28.462046,"eighty":34.169311,"marketCap":2355406832},{"date":"2025-03-07","current":35.240472,"twenty":25.119326,"median":28.45164,"eighty":34.160032,"marketCap":2411787404},{"date":"2025-03-14","current":34.023753,"twenty":25.119326,"median":28.45164,"eighty":34.155864,"marketCap":2328517635},{"date":"2025-03-21","current":34.359618,"twenty":25.119326,"median":28.45164,"eighty":34.155864,"marketCap":2351503561},{"date":"2025-03-28","current":33.646187,"twenty":25.119326,"median":28.45164,"eighty":34.152584,"marketCap":2302677715},{"date":"2025-04-04","current":43.969996,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2495077450},{"date":"2025-04-11","current":43.098027,"twenty":25.122004,"median":28.462046,"eighty":34.151143,"marketCap":2445597555},{"date":"2025-04-17","current":42.514187,"twenty":25.122004,"median":28.462046,"eighty":34.151143,"marketCap":2412467539},{"date":"2025-04-25","current":44.788889,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2541545524},{"date":"2025-05-02","current":45.592617,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2587153079},{"date":"2025-05-09","current":46.828539,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2657285451},{"date":"2025-05-16","current":47.48062,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2694287806},{"date":"2025-05-23","current":46.464587,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2636632973},{"date":"2025-05-30","current":46.305358,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2627597514},{"date":"2025-06-06","current":48.216108,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2736023022},{"date":"2025-06-13","current":47.950726,"twenty":25.119326,"median":28.45164,"eighty":34.131939,"marketCap":2720963923},{"date":"2025-06-20","current":47.776332,"twenty":25.116647,"median":28.436627,"eighty":34.10319,"marketCap":2711067944},{"date":"2025-06-27","current":48.337425,"twenty":25.116647,"median":28.436627,"eighty":34.10319,"marketCap":2742907181},{"date":"2025-07-03","current":40.760766,"twenty":25.116647,"median":28.436627,"eighty":34.10319,"marketCap":2347249494},{"date":"2025-07-11","current":37.908636,"twenty":25.116647,"median":28.436627,"eighty":34.10319,"marketCap":2183006692},{"date":"2025-07-18","current":36.467598,"twenty":25.116647,"median":28.436627,"eighty":34.154024,"marketCap":2100023124},{"date":"2025-07-25","current":37.40708,"twenty":25.116647,"median":28.436627,"eighty":34.161332,"marketCap":2154124099},{"date":"2025-08-01","current":35.992243,"twenty":25.116647,"median":28.436627,"eighty":34.239534,"marketCap":2072649323},{"date":"2025-08-08","current":32.653529,"twenty":25.116647,"median":28.436627,"eighty":34.17599,"marketCap":1880386096},{"date":"2025-08-15","current":33.649154,"twenty":25.116647,"median":28.436627,"eighty":34.140101,"marketCap":1937720197},{"date":"2025-08-22","current":33.469492,"twenty":25.116647,"median":28.436627,"eighty":34.082,"marketCap":1927374194},{"date":"2025-08-29","current":34.667238,"twenty":25.116647,"median":28.436627,"eighty":34.062315,"marketCap":1996347549},{"date":"2025-09-05","current":33.072739,"twenty":25.113969,"median":28.421613,"eighty":34.017965,"marketCap":1904526770},{"date":"2025-09-12","current":32.196888,"twenty":25.116647,"median":28.436627,"eighty":33.971212,"marketCap":1854090004},{"date":"2025-09-19","current":32.526268,"twenty":25.116647,"median":28.436627,"eighty":33.958407,"marketCap":1873057677},{"date":"2025-09-26","current":30.841939,"twenty":25.116647,"median":28.436627,"eighty":33.949365,"marketCap":1776063896},{"date":"2025-10-03","current":40.949393,"twenty":25.116647,"median":28.436627,"eighty":33.958407,"marketCap":1987478781},{"date":"2025-10-10","current":41.028958,"twenty":25.116647,"median":28.436627,"eighty":34.014704,"marketCap":1991340462},{"date":"2025-10-17","current":39.667514,"twenty":25.116647,"median":28.436627,"eighty":34.101864,"marketCap":1925262800},{"date":"2025-10-24","current":39.844325,"twenty":25.116647,"median":28.436627,"eighty":34.180279,"marketCap":1933844315},{"date":"2025-10-31","current":36.979989,"twenty":25.116647,"median":28.447032,"eighty":34.253533,"marketCap":1794823778},{"date":"2025-11-07","current":37.094916,"twenty":25.116647,"median":28.447032,"eighty":34.358647,"marketCap":1800401763},{"date":"2025-11-14","current":37.395495,"twenty":25.116647,"median":28.447032,"eighty":34.405649,"marketCap":1814990337},{"date":"2025-11-21","current":35.04391,"twenty":25.116647,"median":28.447032,"eighty":34.468224,"marketCap":1700856193},{"date":"2025-11-28","current":36.608686,"twenty":25.116647,"median":28.447032,"eighty":34.512555,"marketCap":1776802597},{"date":"2025-12-05","current":38.306071,"twenty":25.116647,"median":28.447032,"eighty":34.591182,"marketCap":1859185138}],"updateTime":1765123183638},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRGS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589870611","title":"United Natural Foods (UNFI): Reassessing Valuation After a Strong Q1 Earnings Beat and Turnaround Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870611","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589870611?lang=en_us&edition=fundamental","pubTime":"2025-12-07 22:18","pubTimestamp":1765117136,"startTime":"0","endTime":"0","summary":"United Natural Foods (UNFI) just delivered one of those quarters that makes investors sit up, topping earnings expectations even as sales dipped slightly, and doubling down on its full year turnaround plan.\nSee our latest analysis for United Natural Foods.\nThat backdrop helps explain why, even after a recent pullback with a 1 month share price return of negative 11.31 percent and a 7 day share price return of negative 8.58 percent, United Natural Foods still shows rebuilding momentum. The 90...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/5022000-choice1-main-header/1585186733105","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5022000-choice1-main-header/1585186733105"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-retailing/nyse-unfi/united-natural-foods/news/united-natural-foods-unfi-reassessing-valuation-after-a-stro","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-retailing/nyse-unfi/united-natural-foods/news/united-natural-foods-unfi-reassessing-valuation-after-a-stro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRGS","UNFI"],"gpt_icon":0},{"id":"2589508874","title":"Bicara Therapeutics (BCAX): Assessing Valuation After Breakthrough Therapy Designation and Early Trial Data Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2589508874","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589508874?lang=en_us&edition=fundamental","pubTime":"2025-12-07 17:30","pubTimestamp":1765099831,"startTime":"0","endTime":"0","summary":"Bicara Therapeutics (BCAX) just put a spotlight on its lead cancer program, pairing early Phase 1b data with an FDA Breakthrough Therapy designation, a one two punch that immediately sharpens the stock’s long term narrative.\nSee our latest analysis for Bicara Therapeutics.\nThe Breakthrough Therapy news arrives after a powerful run, with Bicara’s 1 month share price return of 24.32 percent and 3 month share price return of 48.09 percent. However, the 1 year total shareholder return is still...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bcax/bicara-therapeutics/news/bicara-therapeutics-bcax-assessing-valuation-after-breakthro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bcax/bicara-therapeutics/news/bicara-therapeutics-bcax-assessing-valuation-after-breakthro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BCAX","BK4097","LU2065732104.USD","BK4139","PRGS"],"gpt_icon":0},{"id":"2589094821","title":"Assessing Agnico Eagle Mines (NYSE:AEM) Valuation After Record Profits, Strong Cash Flows and Growth Project Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2589094821","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589094821?lang=en_us&edition=fundamental","pubTime":"2025-12-07 01:24","pubTimestamp":1765041872,"startTime":"0","endTime":"0","summary":"Agnico Eagle Mines (NYSE:AEM) is back in the spotlight as investors digest record profits, hefty free cash flow, and a net cash balance sheet, all while management reiterates steady gold output through 2027.\nSee our latest analysis for Agnico Eagle Mines.\nThe stock’s recent cooling, with a 1 day share price return of minus 1.52 percent and 7 day share price return of minus 3.21 percent to 168.83 dollars, comes after a powerful year to date share price return of 105.92 percent and a standout...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-aem/agnico-eagle-mines/news/assessing-agnico-eagle-mines-nyseaem-valuation-after-record","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-aem/agnico-eagle-mines/news/assessing-agnico-eagle-mines-nyseaem-valuation-after-record","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0300736062.USD","BK4097","LU0266512127.USD","BK4585","LU1223083913.SGD","SG9999001143.SGD","LU0456854461.SGD","LU1223082519.USD","LU0498741890.SGD","LU1169589451.USD","BK4017","LU1169590202.USD","PRGS","LU0300736492.USD","AEM","LU0496367417.USD","LU2065732104.USD","LU0498741114.HKD","LU1223082196.USD","NYSE"],"gpt_icon":0},{"id":"2589859542","title":"QuantumScape (QS) Valuation Check After Cobra Separator Breakthrough and New OEM Partnership Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2589859542","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589859542?lang=en_us&edition=fundamental","pubTime":"2025-12-05 08:27","pubTimestamp":1764894455,"startTime":"0","endTime":"0","summary":"QuantumScape (QS) just checked several big boxes at once, from locking in its Cobra ceramic separator as the production standard to showcasing its QSC5 tech in Ducati field tests and deepening OEM partnerships.\nSee our latest analysis for QuantumScape.\nThese milestones have arrived alongside punchy price action, with the latest share price at $12.97 and a powerful year to date share price return of 134.12 percent. The 1 year total shareholder return of 159.92 percent and 3 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4012000-choice1-main-header/1585186661661","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4012000-choice1-main-header/1585186661661"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/automobiles/nyse-qs/quantumscape/news/quantumscape-qs-valuation-check-after-cobra-separator-breakt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/automobiles/nyse-qs/quantumscape/news/quantumscape-qs-valuation-check-after-cobra-separator-breakt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QS","BK4545","BK4561","LU0823414478.USD","LU2065732104.USD","PRGS","BK4097","BK4540","BK6505","BK4124","BK4551","N0Z.SI","BK6096","LU2249611893.SGD"],"gpt_icon":0},{"id":"2589839244","title":"Beam Therapeutics (BEAM) Is Up 6.8% After Analyst Optimism Around Sickle Cell Base-Editing Progress - What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2589839244","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589839244?lang=en_us&edition=fundamental","pubTime":"2025-12-05 00:18","pubTimestamp":1764865125,"startTime":"0","endTime":"0","summary":"Earlier this week, Beam Therapeutics drew fresh attention as analyst optimism around its sickle cell disease program and manufacturing progress coincided with a sharp uptick in market interest. \nWhat stands out is how confidence in Beam’s base-editing platform and sickle cell pipeline is increasingly being framed by analysts as a potential differentiator in a crowded gene-editing field.\nNow we’ll explore how this renewed analyst confidence in Beam’s sickle cell advances could reshape the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-beam/beam-therapeutics/news/beam-therapeutics-beam-is-up-68-after-analyst-optimism-aroun","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-beam/beam-therapeutics/news/beam-therapeutics-beam-is-up-68-after-analyst-optimism-aroun","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BEAM","BK4556","BK4588","BK4535","BK4585","PRGS","BK4505","BK4097","LU2065732104.USD","BK4139","BK4611"],"gpt_icon":0},{"id":"2588889324","title":"Press Release: MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2588889324","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588889324?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:00","pubTimestamp":1764849600,"startTime":"0","endTime":"0","summary":"-- Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia. -- Topline results from Phase 2 VISTA trial of ML-007C-MA for Alzheimer's. disease psychosis expected in the second half of 2027. -- Raised $296.5 million in gross proceeds from initial public offering and. -- Cash, cash equivalents and short-term investments sufficient to fund. \"2025 was a year of exceptional execution and acceleration for MapLight, \" said Chris Kroeger, Chief Executive Officer of MapLight Therapeutics. \"In the last year, we have made noteworthy progress across our entire product candidate portfolio, including the initiation of the Phase 2 ZEPHYR and VISTA studies for ML-007C-MA, completion of enrollment in our Phase 2 IRIS study of ML-004 and advancement of our preclinical programs. With a strengthened balance sheet following our recent public offering, we are in a strong financial position to continue this momentum to advance our broad and diversified pipeline of potentially best-in-class ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","BK4097","LU0950375773.USD","LU0965508806.USD","BK4139","LU1236620750.USD","BK4106","IE00B5TLWC47.USD","LU1037948897.HKD","LU1691799644.USD","LU1037948541.HKD","LU1934455194.USD","PRGS","IE00BFXG0V08.USD","LU0823417737.USD","GB00B4QBRK32.GBP","LU2404859741.USD","LU1032955483.USD","LU1221951129.SGD","LU1236620834.HKD","LU2065732104.USD","LU1228905540.USD","IPO","LU1934455863.HKD","LU2506952097.USD","LU1221951046.USD","GB00B4LPDJ14.GBP","LU0345774391.USD","LU0965509010.AUD","LU0965509101.SGD","LU0690374615.EUR","LU0690374961.EUR","LU0823417653.USD","IE00BYQQ9H92.USD","LU2404859667.USD","BK4585","LU0345774631.USD","LU1196500208.SGD","BK4613","LU2506951875.HKD","ADP","LU0289941410.SGD","LU0965509283.SGD","BK4130","LU0861579265.USD","LU1228905037.USD","MPLT","BK4588","LU2506952170.USD","LU2506951958.HKD"],"gpt_icon":0},{"id":"2588216920","title":"Xtep (SEHK:1368): Reassessing Valuation After Updated Guidance, Saucony Growth Plans, and Inventory Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2588216920","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588216920?lang=en_us&edition=fundamental","pubTime":"2025-12-03 23:25","pubTimestamp":1764775508,"startTime":"0","endTime":"0","summary":"Xtep International Holdings (SEHK:1368) just reaffirmed its 2025 guidance while outlining an aggressive plan to double Saucony revenue by 2027 through steady store openings and tighter inventory management, with a target inventory level below RMB 2 billion.\nSee our latest analysis for Xtep International Holdings.\nDespite the reaffirmed guidance and Saucony expansion story, the share price has cooled recently, with a 90 day share price return of negative 11.27 percent. At the same time, the 5...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-durables/hkg-1368/xtep-international-holdings-shares/news/xtep-sehk1368-reassessing-valuation-after-updated-guidance-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-durables/hkg-1368/xtep-international-holdings-shares/news/xtep-sehk1368-reassessing-valuation-after-updated-guidance-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1168","LU0702159699.USD","BK1512","PRGS","LU0702159343.USD","01368","LU1166156734.SGD","BK4097","BK1583","BK1502","LU2065732104.USD"],"gpt_icon":0},{"id":"2588904576","title":"Oil Gains on Market Concerns Over Russia-Ukraine Progress -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2588904576","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588904576?lang=en_us&edition=fundamental","pubTime":"2025-12-03 20:35","pubTimestamp":1764765300,"startTime":"0","endTime":"0","summary":"1234 GMT - Oil prices extend gains as markets fear there's a low probability that Russia and Ukraine will soon reach a peace deal after a meeting between Russian President Vladimir Putin and U.S. envoys concluded without an agreement. Brent crude rises 1.1% to $63.14 a barrel, while WTI is up 1.3% to $59.40 a barrel. The lack of a major breakthrough in peace talks, coupled with persistent attacks on Russian energy infrastructure, is driving prices higher. However, both Brent and WTI remain within tight trading ranges as concerns over excess global supply continue to weigh on the oil outlook. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","LU2065732104.USD","PRGS"],"gpt_icon":0},{"id":"2588409046","title":"Today's Top 3 News: PT GoTo Gojek Tokopedia Responds to Grab Merger Progress: \"Open to Discussions\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2588409046","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588409046?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:10","pubTimestamp":1764760208,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -Tempo Englishcompiled thetop 3 newson Wednesday, December 3, 2025. Here are the highlights: PT GoTo Gojek Tokopedia Responds to Grab Merger Progress: \"Open to Discussions\"; Prabowo Departs for Sumatra to Inspect Disaster-Hit Areas; and Singaporean Tourists to Benefit from Johor Bahru-Kuala Lumpur Electric Train Service.The following is the list of the top 3 news onTempo Englishtoday:1. PT GoTo Gojek Tokopedia Responds to Grab Merger Progress: \"Open to Discussions\". PT GoTo Gojek Tokopedia Tbk  has responded to developments regarding a potential business merger withGrab Indonesia, a plan the government recently confirmed is still under discussion.","market":"fut","thumbnail":"https://statik.tempo.co/data/2021/05/28/id_1024156/1024156_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2021/05/28/id_1024156/1024156_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2070689/todays-top-3-news-pt-goto-gojek-tokopedia-responds-to-grab-merger-progress-open-to-discussions","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2070689/todays-top-3-news-pt-goto-gojek-tokopedia-responds-to-grab-merger-progress-open-to-discussions","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["LU1242518931.SGD","PT",".IXIC","GRAB","SG9999013460.SGD","BK4166","LU1839390173.USD","SG9999001135.SGD","BK4122","LU0441851309.USD","LU2065732104.USD","SG9999002620.SGD","SG9999013486.USD","SG9999002679.SGD","BK4022","LU0210637038.USD","SGXZ58947870.SGD","SG9999002604.SGD","BK4230","LU0979878070.USD","BK4232","SG9999013478.USD","SG9999002414.USD","LU2362540622.SGD","LU1242518857.USD","BK4097","LU2362541513.USD","PRGS","LU2125910500.SGD","LU0532188223.SGD","LU2362541273.HKD","LU2045819591.USD","SG9999006266.SGD","SG9999002406.SGD","ETS"],"gpt_icon":1},{"id":"2588874590","title":"Royal Group Celebrates the Success of \"Rise for Khmer\" Concert, Reaffirming Its Commitment to Culture, Unity, and National Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2588874590","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588874590?lang=en_us&edition=fundamental","pubTime":"2025-12-02 15:11","pubTimestamp":1764659460,"startTime":"0","endTime":"0","summary":"SINGAPORE and PHNOM PENH, Cambodia, Dec. 2, 2025 /PRNewswire/ -- Royal Group is proud to announce the resounding success of theRise for Khmer, Stand for Peace concert held at Salle Pleyel, Paris. An event that powerfully celebrated Cambodian resilience, culture, and unity. The concert was graciously attended by Her Excellency, Phoeurng Sackona, Minister of Culture and Fine Arts of Cambodia, whose presence further underscored the importance of preserving and uplifting Khmer identity and artistic expression.Since 1991, under Chairman Neak Oknha Kith Meng, Royal Group has become a Cambodian institution built by Cambodians, for Cambodia. ","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2836185/RGC__Rise_for_Khmer__Press_Release_01.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2836185/RGC__Rise_for_Khmer__Press_Release_01.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/royal-group-celebrates-the-success-of-rise-for-khmer-concert-reaffirming-its-commitment-to-culture-unity-and-national-progress-302630061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRGS","RGLD","LU2065732104.USD","LU0345780521.USD","BK4017","BK4097","UNTY","NHLD","BK4211","BK4588","BK4585","LU0345780281.USD"],"gpt_icon":0},{"id":"2588858120","title":"Did FDA Green Light for ELEVIDYS and Pipeline Progress Just Shift Sarepta Therapeutics' (SRPT) Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2588858120","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588858120?lang=en_us&edition=fundamental","pubTime":"2025-12-02 09:15","pubTimestamp":1764638157,"startTime":"0","endTime":"0","summary":"In late November 2025, Sarepta Therapeutics announced two major developments: FDA approval to begin dosing non-ambulant Duchenne muscular dystrophy patients with ELEVIDYS in a new ENDEAVOR study cohort, and progress in the Phase 1/2 multiple ascending dose clinical trial for SRP-1003, its investigational siRNA therapy for type 1 myotonic dystrophy.\nThese advancements underscore Sarepta's commitment to expanding its pipeline and addressing rare neuromuscular diseases with innovative genetic...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/did-fda-green-light-for-elevidys-and-pipeline-progress-just","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srpt/sarepta-therapeutics/news/did-fda-green-light-for-elevidys-and-pipeline-progress-just","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BJJMRZ35.SGD","IE0009355771.USD","SRPT","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","PRGS","BK4097","BK4139","LU2065732104.USD","IE00BJT1NW94.SGD","BK4585"],"gpt_icon":0},{"id":"2588709771","title":"A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Q3 2025 Results and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2588709771","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588709771?lang=en_us&edition=fundamental","pubTime":"2025-12-02 04:13","pubTimestamp":1764619990,"startTime":"0","endTime":"0","summary":"Zai Lab (NasdaqGM:ZLAB) just shared its Q3 2025 results, highlighting ongoing product revenue growth driven by NUZYRA and XACDURO, as well as solid progress in its clinical development pipeline.\nSee our latest analysis for Zai Lab.\nAfter a tough year for shareholders, Zai Lab's recent commercial wins and pipeline progress have sparked some optimism, but the share price still reflects lingering caution. Despite the management’s upbeat tone and new clinical milestones, the 1-year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/a-look-at-zai-lab-nasdaqgmzlab-valuation-following-q3-2025-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zlab/zai-lab/news/a-look-at-zai-lab-nasdaqgmzlab-valuation-following-q3-2025-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4097","BK4548","ZLAB","BK4526","BK4139","LU2488822045.USD","BK4585","BK4588","PRGS","LU2065732104.USD","BK4531"],"gpt_icon":0},{"id":"2588704897","title":"Assessing SSY Group (SEHK:2005) Valuation Following New Drug Approvals and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2588704897","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588704897?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:16","pubTimestamp":1764609400,"startTime":"0","endTime":"0","summary":"SSY Group (SEHK:2005) just secured multiple new drug production and registration approvals from China’s National Medical Products Administration, spanning both specialty treatments and bulk drugs. This signals tangible advancement in the company’s pharmaceutical pipeline.\nSee our latest analysis for SSY Group.\nAfter a challenging start to the year, SSY Group’s share price has shown renewed momentum, achieving a 9.5% return over the past 90 days and rising 1.6% just yesterday as investors...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/assessing-ssy-group-sehk2005-valuation-following-new-drug-ap","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/assessing-ssy-group-sehk2005-valuation-following-new-drug-ap","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2460026573.USD","PRGS","LU2065732104.USD","SSY","BK4097","DCF","BK1191","BK4185","02005"],"gpt_icon":0},{"id":"2588777317","title":"Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2588777317","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588777317?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:00","pubTimestamp":1764597600,"startTime":"0","endTime":"0","summary":"FREEHOLD, N.J., Dec.  01, 2025  (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced a series o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/01/3197069/0/en/Avalon-GloboCare-Reports-Q3-2025-Progress-with-KetoAir-Holistic-Health-Initiatives-and-International-Expansion.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","LU2065732104.USD","BK4097","ALBT","BK4205","PRGS"],"gpt_icon":0},{"id":"2588727820","title":"Press Release: Pulse Oil Corp. Announces Amendments to Facility Agreements and Updates EOR Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2588727820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588727820?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:33","pubTimestamp":1764592380,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, Dec. 01, 2025  -- Pulse Oil Corp.   is pleased to announce that Pulse has entered into amending agreements to the two loan Facility Agreements  with two arms-length parties to the Company  announced in the Company's press release of June 5, 2025. Pursuant to the amending agreements, each of the Lenders has agreed to increase their respective loan to the Company , in aggregate, from the sum of $2,250,000 to $4,250,000 . In addition, the Loan maturity dates have been revised to June 9, 2026, unless the Lender and Borrower agree to the Maturity Date Extension defined in the Facility Agreements, whereby the Lenders and Pulse can agree to extend the Maturity Date by six months.Pulse Oil Corp. CEO, Garth Johnson commented, \"This add","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","API","BK4551","BK4097","BK4023","BK4535","BK4503","PRGS"],"gpt_icon":0},{"id":"2588723887","title":"Sean Duffy Says Airbus A320 Software Recall Won't Cause 'Major' Disruptions For Travelers: 'Great Progress...'","url":"https://stock-news.laohu8.com/highlight/detail?id=2588723887","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588723887?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:05","pubTimestamp":1764579900,"startTime":"0","endTime":"0","summary":"Transportation Secretary Sean Duffy reassures travelers about Airbus software recalls, saying delays and disruptions are not expected.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/01/Sean-Duffy.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/01/Sean-Duffy.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/travel/25/12/49130200/sean-duffy-says-airbus-a320-software-recall-wont-cause-major-disruptions-for-travelers-great-progress","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/travel/25/12/49130200/sean-duffy-says-airbus-a320-software-recall-wont-cause-major-disruptions-for-travelers-great-progress","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IE00BKVL7J92.USD","BK4585","BK4547","UAL","BK4008","TRV","LU2065732104.USD","LU0310800965.SGD","BK4588","DAL","BK4500","AAL","BK4107","LU0128525689.USD","BK4097","BK4533","LU0052756011.USD","LU1267930227.SGD","PRGS","IE00B1BXHZ80.USD","IE00BZ1G4Q59.USD","IE00BFMHRM44.USD"],"gpt_icon":0},{"id":"2588718465","title":"Avis Budget Group (CAR): Valuation in Focus After Strong Q3 Results and International Expansion Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2588718465","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588718465?lang=en_us&edition=fundamental","pubTime":"2025-12-01 00:13","pubTimestamp":1764519185,"startTime":"0","endTime":"0","summary":"Avis Budget Group (CAR) posted stronger-than-expected results for the third quarter, as both earnings and revenues beat consensus forecasts. Investors are now watching closely, particularly with international adjusted EBITDA growth in focus and evolving transportation trends under consideration.\nSee our latest analysis for Avis Budget Group.\nThis positive earnings surprise arrives as Avis Budget Group’s share price continues to show robust momentum, with a year-to-date price return of nearly...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3242000-choice2-main-header/1585186741316","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3242000-choice2-main-header/1585186741316"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/transportation/nasdaq-car/avis-budget-group/news/avis-budget-group-car-valuation-in-focus-after-strong-q3-res","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/transportation/nasdaq-car/avis-budget-group/news/avis-budget-group-car-valuation-in-focus-after-strong-q3-res","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065732104.USD","PRGS","BK4097","BK4022","CAR.AU","CAR","BK7002","BK4230","BK7503"],"gpt_icon":0},{"id":"2587760747","title":"Is Arrowhead a Bargain After Clinical Trial Progress Fuels 168% Jump in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2587760747","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587760747?lang=en_us&edition=fundamental","pubTime":"2025-11-30 08:27","pubTimestamp":1764462479,"startTime":"0","endTime":"0","summary":"If you have ever wondered whether Arrowhead Pharmaceuticals is truly a bargain or just looks like one, you are in the right place. Let’s dig into what the numbers really say about its value.\nThe stock has soared recently, climbing 30.3% in the past week, 24.6% over the past month, and an astonishing 168.2% year-to-date. This suggests that investor optimism and perhaps risk perceptions have shifted quickly.\nMuch of this excitement comes after Arrowhead announced promising clinical trial...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arwr/arrowhead-pharmaceuticals/news/is-arrowhead-a-bargain-after-clinical-trial-progress-fuels-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arwr/arrowhead-pharmaceuticals/news/is-arrowhead-a-bargain-after-clinical-trial-progress-fuels-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FCF","BK4211","BK4097","LU2065732104.USD","DCF","PRGS","BK4139","BK4588","ARWR","BK4585"],"gpt_icon":0},{"id":"2587798864","title":"Ultragenyx Pharmaceutical (RARE): Evaluating Valuation After Analyst Commentary on Setrusumab Progress and Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2587798864","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587798864?lang=en_us&edition=fundamental","pubTime":"2025-11-30 08:22","pubTimestamp":1764462149,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical (RARE) captured attention after a recent analyst update on its setrusumab clinical program. This development coincided with reports of strong revenue growth and increasing momentum behind several late-stage drug candidates.\nSee our latest analysis for Ultragenyx Pharmaceutical.\nUltragenyx’s recent surge in activity, including clinical milestones and upbeat revenue reports, appears to have lifted investor sentiment. A robust 16% 90-day share price return reflects...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rare/ultragenyx-pharmaceutical/news/ultragenyx-pharmaceutical-rare-evaluating-valuation-after-an","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rare/ultragenyx-pharmaceutical/news/ultragenyx-pharmaceutical-rare-evaluating-valuation-after-an","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065732104.USD","BK4139","RARE","PRGS","BK4097"],"gpt_icon":0},{"id":"2587510397","title":"Prabowo Claims His First Year in Office Has Shown Tangible Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2587510397","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587510397?lang=en_us&edition=fundamental","pubTime":"2025-11-29 10:47","pubTimestamp":1764384457,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Indonesian President Prabowo Subianto claims that the government has shown tangible results in the first year of his leadership. According to Prabowo, the government has achieved commendable feats.\"I feel that in the one year of my leadership, we have proven to the entire Indonesian people tangible results. Achievements that we can be proud of,\" Prabowo said in his address at the annual meeting of Bank Indonesia  2025 at Graha Bhasvara Icchana, Bank Indonesia Head Office, Jakarta, on Friday, November 28, 2025.He initially stated that Indonesia's economy shows promise amid global uncertainties. The world is experiencing a trade war, economic warfare, and hegemonic competition.","market":"other","thumbnail":"https://statik.tempo.co/data/2025/11/29/id_1444234/1444234_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/11/29/id_1444234/1444234_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2069557/prabowo-claims-his-first-year-in-office-has-shown-tangible-progress","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2069557/prabowo-claims-his-first-year-in-office-has-shown-tangible-progress","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["PRGS","LU2065732104.USD","MBG","BK4097"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}